| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |